Healthcare Jul 30, 2021 09:36 AM (GMT+8) · EqualOcean
On the 30th, yiouda health learned that Sox medical, a clinical digital medical sensor enterprise, recently completed hundreds of millions of yuan of round C financing, which was led by Lanxin Asia and China Merchants Bank International Capital, followed by Huachuang capital, Sinopharm capital, Dongfang Fuhai and Hangjin investment. The old shareholders Weisi capital and dark horse fund continued to increase their weight, and potential capital acted as the exclusive financial adviser. Sox medical, founded in 2016, is mainly engaged in the research and development of flexible wearable medical devices and the use of medical big data to assist doctors in artificial intelligence diagnosis and analysis. According to the official website, 13 products independently developed by SOX medical have obtained nmpa medical device product registration certificate and 30 patents. The products cover the fields of ambulatory ECG monitoring, continuous body temperature monitoring and fetal ECG monitoring. More than 1 million hospitals have registered nmpa Wearable ECG sensor products, among which more than 1 million hospitals have obtained the "core ECG sensor" product. Gao Linming, founder of Sox medical, said: "this round of financing will be used in three aspects: first, continue to expand the marketing service team, expand market channels and improve the service system with 'customer success as the core'; Second, strengthen the research and development of new products, from focusing on a single disease to multi sign data products; Third, layout the upstream industrial chain and increase investment in basic research such as chips and new materials. "

This text is a result of machine translation.